Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Eugene Han, Yong-ho Lee

Clin Mol Hepatol. 2023;29(4):980-983. Published online August 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0250

View: 1512 Download: 82

Eun Haeng Jeong, Dae Won Jun, Yong Kyun Cho, Young Gil Choe, Seungho Ryu, Seung Min Lee, Eun Chul Jang

Clin Mol Hepatol. 2013;19(3):266-272. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.266

View: 9156 Download: 98 Crossref: 67

Dong Min Lee , Seung Ok Lee , Byoung Sik Mun , Heok Soo Ahn , Hye Young Park* , Hye Soo Lee* , Dae Ghon Kim

Clin Mol Hepatol. 2002;8(4):355-362. Published online January 1, 1970

View: 2228 Download: 21

1 |

Viewed By 5282	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5231	MAFLD: How is it different from NAFLD?
Viewed By 5128	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3850	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3787	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search